Welcome to our dedicated page for Health Catalyst news (Ticker: HCAT), a resource for investors and traders seeking the latest updates and insights on Health Catalyst stock.
Health Catalyst, Inc. (HCAT) delivers data analytics and technology solutions that empower healthcare organizations to improve clinical outcomes. This page serves as a comprehensive resource for investors and industry professionals tracking the company’s strategic developments.
Key updates include earnings reports, product launches, leadership changes, and partnership announcements. Users will find verified press releases and curated news articles covering HCAT’s technology innovations, client expansions, and financial performance.
Regular updates feature developments in healthcare data warehousing, cloud analytics platforms, and professional service offerings. Content highlights operational milestones, regulatory compliance achievements, and market expansion efforts within the healthcare IT sector.
Bookmark this page to monitor Health Catalyst’s progress in enabling data-driven care improvements through its adaptive data architecture and analytics expertise. Check back for objective reporting on HCAT’s role in advancing healthcare interoperability and operational efficiency.
Health Catalyst (Nasdaq: HCAT) announced that Matt Arens, CEO and founder of First Light Asset Management and representative of the company's largest shareholder, joined the board effective Dec. 1, 2025. First Light and Arens collectively own approximately 13.9 million shares, or about 19% of outstanding common stock. The company said Arens brings capital-markets experience focused on micro- to mid-cap healthcare investing and that his perspective will support strategic focus and shareholder value efforts.
The release also said director Matthew Kolb will not stand for re-election at the 2026 annual meeting and will continue to serve until that meeting.
Health Catalyst (Nasdaq: HCAT) said senior management will participate in multiple investor conferences in Nov–Dec 2025. Key events and appearances include:
- Nov 19, 2025, 3:00pm CT – Fireside chat at The Stephens Annual Investment Conference in Nashville with Ben Albert, Jason Alger, and Matt Hopper.
- Nov 20, 2025 – 1x1 meeting opportunities at Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum in New York with Dan Burton, Ben Albert, Jason Alger, and Matt Hopper.
- Dec 2, 2025, 8:20am ET – Fireside chat at the 8th Annual Evercore Healthcare Conference in Miami with Dan Burton, Ben Albert, Jason Alger, and Matt Hopper.
- Dec 3, 2025 – 1x1 meeting opportunities at Citi’s 2025 Global Healthcare Conference in Miami with Dan Burton, Ben Albert, Jason Alger, and Matt Hopper.
The announcements list dates, times, locations, and participating executives for investor engagement in late 2025.
Health Catalyst (Nasdaq: HCAT) reported third-quarter 2025 results for the period ended September 30, 2025: total revenue $76.3M, Adjusted EBITDA $12.0M, and GAAP net loss $(22.2M). Management said results beat quarterly guidance and reaffirmed full-year 2025 guidance. Other reported metrics include adjusted gross profit $40.1M (53% margin) and GAAP gross profit $30.0M (39% margin).
Guidance: Q4 2025 revenue ~$73.5M and Adjusted EBITDA ~$13.4M; full-year 2025 revenue ~$310M and Adjusted EBITDA ~$41M. A conference call was scheduled for November 10, 2025.
Health Catalyst (Nasdaq: HCAT) announced on Nov 10, 2025 that UnityPoint Health will migrate from Health Catalyst's legacy data platform to the next‑generation Health Catalyst Ignite™ Data and Analytics platform.
UnityPoint Health has partnered with Health Catalyst since 2016 and reported generating millions in value over nine years using the legacy platform. The migration aims to scale those results by enabling faster insights, centralized governance, data sharing where data resides, reduced storage and management costs, democratized analytics, and infrastructure to deploy future‑ready AI solutions for improved decision‑making and patient care.
Health Catalyst (Nasdaq: HCAT) announced that three products—Twistle, Lumeon, and Upfront—have earned HITRUST r2 certification for information security, signaling compliance with demanding regulatory and industry requirements.
Twistle was certified in September 2025, Lumeon in June 2025, and Upfront’s Emerald solution earned r2 in December 2024 with Upfront’s Ruby achieving HITRUST e1 in August 2025. The company says these certifications reinforce its data protection and compliance commitments.
Health Catalyst (Nasdaq: HCAT) will release its third quarter 2025 operating results on Monday, November 10, 2025, after market close.
The company will host a conference call to review results on November 10, 2025 at 5:00 pm ET. U.S. participants can dial 800-343-5172, international participants can dial 203-518-9856, and the conference ID is HCATQ325. A live audio webcast and on-demand replay will be available at https://ir.healthcatalyst.com/, with the replay accessible for approximately 90 days.
Healthmine, a member engagement and rewards platform for health plans, has appointed Dwight Erskine as its new Chief Executive Officer, effective September 15, 2025. Erskine, with over 25 years of healthcare technology experience, succeeds Bryce Williams, who will transition to an advisory role.
Prior to joining Healthmine, Erskine served as Senior Vice President of Enterprise Transformation at VillageMD and healthcare leader at Synergetics. Under his leadership, Healthmine aims to expand its technology and strengthen partnerships. The company has already achieved significant milestones in 2025, including launching AI-supported patient scheduling, improved in-home assessment connectivity, and strategic partnerships with Exact Sciences and Tenasol.
Health Catalyst (NASDAQ:HCAT) has appointed Ben Albert as President and Chief Operating Officer. Albert, who previously served as CEO & Co-Founder of Upfront Healthcare Services until its acquisition by Health Catalyst, brings over 25 years of healthcare leadership experience.
This appointment comes as current CEO Dan Burton prepares for his previously announced retirement in June 2026. Albert will oversee day-to-day operations with senior leaders in Product Engineering, Technology Delivery and Support, Growth, Operations, Finance, and Corporate Strategy reporting to him. Additionally, Dan LeSueur will transition from his full-time role to a part-time advisory position supporting the leadership transition.
Health Catalyst (NASDAQ:HCAT) has expanded its partnership with CyncHealth Nebraska, the state's health information exchange (HIE), to enhance the delivery of Continuity of Care Documents (CCDs). The collaboration will leverage Health Catalyst's Ninja Universe technology, an advanced parsing tool designed to improve healthcare data exchange.
The partnership aims to provide more accurate, timely, and secure patient health information sharing across Nebraska's healthcare systems. This initiative will support clinical decision-making and care coordination by streamlining how CCDs are parsed and shared throughout the HIE network.
Health Catalyst (NASDAQ:HCAT) announced the winners of its 2025 Catalyst Awards at the Health Catalyst Analytics Summit in Salt Lake City. The awards recognized 28 healthcare organizations for excellence in data-driven healthcare transformation across five categories.
Key winners include: Lifepoint Health for Care Quality Excellence, saving 700+ lives through improved sepsis care; Temple University Health System for Financial Transformation, generating millions in revenue through activity-based costing; Revere Medical for Quality Performance, achieving significant improvements in patient care metrics; INTEGRIS Health for Organizational Transformation, securing $32.7 million in combined cost savings; and Innovative Healthcare Collaborative of Indiana for Population Health Impact, achieving $28.3 million in cost reductions.
FAQ
What is the current stock price of Health Catalyst (HCAT)?
What is the market cap of Health Catalyst (HCAT)?
